The endothelium plays a central role in overall vascular homeostasis by regulating vasoreactivity, platelet activation, leukocyte adhesion, and smooth muscle cell proliferation and migration. Endothelial nitric oxide (NO), an important vasoprotective molecule, is a major modulator of these effects, and impaired NO signaling associated with endothelial function is considered as an early marker of the atherogenic process.
1 Arginase competitively inhibits nitric oxide synthase (NOS) by using the common substrate Larginine. [2] [3] [4] Arginase is present in two isoforms as arginase I, the hepatic isoform, and arginase II, the extrahepatic isoform, each of which is encoded by a distinct gene. Arginase activation/upregulation results in arginase/NOS imbalance, decrease NO production, and contributes to endothelial dysfunction in a number of pathophysiological processes such as aging, 2 diabetes, 5 hypertension, 6, 7 and atherosclerosis.
8,9
Additionally, arginase enhances production of reactive oxygen species by eNOS. Arginase inhibition in hypercholesterolemic (ApoE(-/-)) mice or arginase II deletion (ArgII(-/-)) mice restores endothelial vasorelaxant function, reduces vascular stiffness, and markedly reduces atherosclerotic plaque burden. Furthermore, arginase activation contributes to vascular changes including polyamine-dependent vascular smooth muscle cell proliferation and collagen synthesis. Collectively, arginase may play a key role in the prevention and treatment of atherosclerotic vascular disease.
10,11
Saururus chinensis Baill. belongs to the family Saururaceae and is an endemic species in Korea. As a traditional medicine, S. chinensis has been used to treat beriberi, pneumonia, edema, urination, jaundice, and gonorrhea. 12 This plant has been investigated extensively, resulting in the isolation of various lignans (sauchinone, saucerneol, manassantin A, and manassantin B), flavonoids (rutin, hyperoside, quercitrin and quercetin) and alkaloid (aristolactam BII). [13] [14] [15] Many bioactive compounds have been reported from the extract of S. chinensis and shown strong antioxidant activity, 16, 17 and its extract has been shown to induce apoptosis through the activation of caspase-3 in prostate and breast cancer cells, 18 and to reduce lipid peroxide levels in rats fed a high-fat diet, 19 and in rats with carbon tetrachloride-induced hepatic fibrosis.
20 Saucerneol D, a lignan constituent of S. chinensis, efficiently inhibited melanin production, 21 and showed antioxidant and antiasthmatic effects in a mouse model of airway inflammation. 22 In our continuing investigation to discover inhibitors of arginase II, further fractionation of the EtOAc-soluble fraction resulted in the isolation of a new compound (1), along with nine known compounds (2) (3) (4) (5) (6) (7) (8) (9) (10) . This study describes the isolation, structural elucidation of these isolates and their inhibitory arginase II activity.
The MeOH extract of the aerial part of S. chinensis was partitioned into n-hexane-, EtOAc-, and n-BuOH-soluble fractions and a H 2 O layer. Chromatographic purification of the EtOAc-soluble fraction led to the isolation of ten compounds (1-10) (Fig. 1) . The structures of known compounds were identified as sauchinone (2) , (9), 29 and licarin A (10), 30 by comparing their physiochemical and spectroscopic data with those reported in the literature.
Compound 1 was isolated as white amorphous powder, with the molecular formula C 20 H 20 O 7 , as determined by the HR-EIMS at m/z 372.1209 for the [M] + ion (calcd. for C 20 H 20 O 7 , 372.1209). The optical rotation value is −9.5 (c = 0.37, CHCl 3 ) and the UV spectrum exhibited λ max at 244 and 297 nm (CHCl 3 ). The 1 H NMR spectra showed the presence of two aromatic protons (δ 6.43 and 7.00) and two methylenedioxy groups, one ( C NMR spectral data between 1 and sauchinone (2) suggested that compound 1 was similar with 2 previously isolated from Saururus chinensis. 23 However, the methine proton at position C-7 of sauchinone (2) was substituted by a hydroxyl group at [δ H 5.55 (1H, br s, 7-OH), δ C 68.9], and it was further confirmed by HMBC spectrum. The HMBC spec- trum showed the long-range correlation between proton signals at δ H 7.00 (H-6), 2.52 (H-8), 1.25 (H-9), 2.53 (H-1'), and 2.62 (H-6') and carbon signal at δ C 68.9, and then these correlations suggested that hydroxyl group was located at C-7 (Fig. 2) . From COSY, NOESY, and HMBC data, we concluded that 1 is a derivative of sauchinone (2) ( Table 1 and Fig. 2) . From the NOESY spectrum (measured in pyridine-d 5 ), the proton at δ H 5.55 (7-OH) displayed NOEs with the methyl protons signal at δ H 1.46 (9-CH 3 ) and 2.90 (H-6'), and the methine resonance at δ H 2.70 (H-1') displayed NOEs with the methyl protons of δ H 0.61 (9'-CH 3 ) and 1.93 (7'-H eq ). Furthermore, the methine proton signal at δ H 2.90 (H-6') also displayed NOEs with the methyl proton signals at δ H 1.46 (9-CH 3 ), 5.55 (7-OH), and 2.04 (7'-H ax ). Hence, the configurations of 7-OH, 6'-H, and 1'-H are a cis-trans form by comparison with the cis-trans form in sauchinone (2) . Based on the above analysis, the structure of compound 1 was elucidated as 7-hydroxysauchinone.
Arginase II activity is upregulated in atherosclerosis-prone mice and is associated with impaired endothelial NO production, endothelial dysfunction, vascular stiffness, and ultimately, aortic plaque development. Conversely, inhibiting endothelial arginase or deleting the arginase II gene enhances NO production, restores endothelial function and aortic compliance, and reduces plaque burden. Therefore, arginase II represents a novel target for preventing and treating of atherosclerotic vascular disease. 8 In the present study, we screened the isolated compounds for anti-arginase II activity. Incubating compounds 1 and 2 from kidney lysates significantly inhibited arginase II activity with IC 50 values of 89.6 and 61.4 μM (Table 2) , respectively, whereas the other compounds were apparently inactive.
Experimental
General Experimental Procedure. Optical rotations were measured with a JASCO DIP 370 digital polarimeter. UV spectra were taken in MeOH using a Thermo spectrometer. The nuclear magnetic resonance (NMR) spectra were obtained on Varian Unity Inova 400 MHz spectrometer. Silica gel (Merck, 63-200 μm particle size), RP-18 (Merck, 75 μm particle size) were used for column chromatography. TLC was carried out using Merck silica gel 60 F 254 and RP-18 F 254 plates. HPLC was carried out using a Water system (515 pump) with a UV detector (486 Tunable Absorbance) and an YMC Pak ODS-A column (20 × 250 mm, 5 μm particle size, YMC Co., Ltd., Japan) and HPLC solvents were from Burdick & Jackson, USA.
Plant Material. The dried aerial part of S. chinensis was purchased from a local folk medicine market named "Yakryoung-si" in Daegu, Korea, in May 2010. Botanical identification was performed by Prof. Byung-Sun Min, and the voucher specimen CUD-1384 was deposited at the herbarium of the College of Pharmacy, Catholic University of Daegu, Korea.
Extraction and Isolation. The dried aerial part of S. chinensis (12 kg) was extracted three times with MeOH at room temperature for seven days and then MeOH extract (1.5 kg) was suspended in hot-water (4 L) and partitioned with n-hexane (4 L × 3), ethyl acetate (4 L × 3), and nbutanol (4 L × 3), successively. The resulting fractions were concentrated in vacuo to give the hexane-soluble fraction (400.8 g), EtOAc-soluble fraction (584.93 g), and BuOHsoluble fraction (314.2 g), respectively. By the activityguided fractionation, the EtOAc soluble fraction (584.93 g) was chromatographed on a silica gel column chromatography eluting with a gradient of CHCl 3 -MeOH (50:1 → 5:1) to afford fifteen fractions (Fr. 1~15). Fraction 7 (80 g) was subjected on a silica gel column chromatography eluting with a gradient of n-hexane-acetone (5:1 → 0:1) to afford three subfractions (Fr. 7-1~7-3). Subfraction 7-1 (20 g) was subjected on a silica gel column chromatography eluting with a gradient of n-hexane-EtOAc (10:1 → 1:1) to afford compounds 2 (120 mg), 3 (32.8 mg), and 4 (25 mg). Subfraction 7-2 (25 g) was subjected to silica gel column chromatography with a gradient of n-hexane-EtOAc (5:1 → 1:1) to afford seven subfractions (Fr. 7-2-1~7-2-7). Subfraction 7-2-5 (450 mg) was chromatographed over a RP-18 gel eluting with a gradient of MeOH-H 2 O (3:1 → 6:1) to afford compounds 8 (12.3 mg), 9 (8 mg), 6 (34.4 mg), and 7 (17 mg). Subfraction 7-2-2 was chromatographed by MPLC on a ODS column using MeOH-H2O (3:1) and purified by preparative HPLC on a RP-18 column using MeOH-H 2 O (72:28 → 74:26) to yield compound 10 (8 mg). Subfraction 7-2-6 was chromatographed by MPLC on a ODS column using MeOH-H 2 O (3:1) followed by re-crystallization to yield compound 1 (10.9 mg) and 5 (7.2 mg), respectively. Notes using lysis buffer (50 mM Tris-HCl, pH7.5, 0.1 mM EDTA and protease inhibitors) by homogenization at 4 °C followed by centrifugation for 20 min at 14,000 × g at 4 °C. Briefly, aortic lysates were added to Tris-HCl. The hydrolysis reaction of L-arginine by Arg was performed by incubating the mixture containing activated Arg and was stopped by adding acid solution. For calorimetric determination of urea, α-isonitrosopropiophenone was added, and the mixture was heated at 100 °C for 45 minutes. After placing the sample in the dark for 10 minutes at room temperature, the urea concentration was determined spectrophotometrically by the absorbance at 550 nm. 
